L. Cortivo

发表

Transduction of CD34+ PBSC Mobilized in Cancer Patients Using a Novel Fr-MuLV Retrovirus Vector Derived from FB29 Highly Titrating Strain

M. Marty, J. Marolleau, M. Benbunan, 1998 .

The Challenge in Hematopoietic Stem Cell Transplantation: Shortening the Immunodeficiency Period

A. Fischer, Y. Hamel, M. Cavazzana‐Calvo, 2010 .

Angiogenic potential of BM MSCs derived from patients with critical leg ischemia

J. Emmerich, J. Silvestre, P. Gaussem, 2012, Bone Marrow Transplantation.

The effects of transurethral resection and cystoprostatectomy on dissemination of epithelial cells in the circulation of patients with bladder cancer

F. Hamdy, P. Teillac, P. Bertheau, 1999, British Journal of Cancer.

Impact of HLA matching on outcome of hematopoietic stem cell transplantation in children with inherited diseases: a single-center comparative analysis of genoidentical, haploidentical or unrelated donors

A. Fischer, F. Deist, J. Casanova, 2004, Bone Marrow Transplantation.

immunodeficiency single-center cohort of 90 patients with severe combined Long-term outcome after hematopoietic stem cell transplantation of a

A. Fischer, J. Casanova, C. Picard, 2013 .

Blood stem cell collection using chemotherapy with or without systematic G-CSF: experience in 52 patients with multiple myeloma

J. Fermand, J. Marolleau, M. Benbunan, 1999, Bone Marrow Transplantation.

Use of hematopoietic progenitor cell count on the Sysmex XE-2100 for peripheral blood stem cell harvest monitoring

F. Ajchenbaum‐Cymbalista, R. Letestu, L. Garçon, 2007, Leukemia & lymphoma.

First experience of autologous peripheral blood stem cell mobilization with biosimilar granulocyte colony- stimulating factor

C. Elie, M. Cavazzana‐Calvo, O. Hermine, 2011, Advances in therapy.

granulocyte colony-stimulating factor peripheral blood progenitor cells mobilized by chemotherapy and Granzyme B and perforin lytic proteins are expressed in CD34+

C. Berthou, M. Benbunan, L. Cortivo, 2011 .

Influence of CD34+ marrow cell dose on outcome of HLA-identical sibling allogeneic bone marrow transplants in patients with chronic myeloid leukaemia

S. Chevret, H. Bittencourt, H. Esperou, 2001, Bone Marrow Transplantation.

Association of CD 34 cell dose with hematopoietic recovery , infections , and other outcomes after HLA-identical sibling bone marrow transplantation

S. Chevret, H. Bittencourt, H. Esperou, 2002 .

Enrichment of peripheral blood CD34+ cells for transplantation using a fully automated immunomagnetic cell selection system and a novel octapeptide releasing agent

C. Gisselbrecht, J. Lotz, J. Fermand, 1999, Bone Marrow Transplantation.

Evaluation of an algorithm based on peripheral blood hematopoietic progenitor cell and CD34+ cell concentrations to optimize peripheral blood progenitor cell collection by apheresis

Sarah Zohar, R. Letestu, M. Cavazzana‐Calvo, 2007, Transfusion.

The VAD chemotherapy regimen plus a G-CSF dose of 10 μg/kg is as effective and less toxic than high-dose cyclophosphamide plus a G-CSF dose of 5 μg/kg for progenitor cell mobilization: results from a monocentric study of 82 patients

G. Damaj, O. Hermine, S. Zohar, 2006, Bone Marrow Transplantation.